Biosimilar Preferred Drug List (PDL) 2026 Update
This message replaces the former messages sent on November 17, 2025, and November 18, 2025.
Effective January 1, 2026, the Department will add preferred and non-preferred drugs to the Biosimilar PDL.
|
Biosimilar Preferred Drug List 2026 Effective January 1, 2026 |
|
Bevacizumab and Biosimilars |
|
Preferred Drugs |